Abiraterone
Abiraterone acetate
- Strength
- 250 mg/1
- Form
- Tablet
- Class
- Cytochrome P450 17A1 Inhibitor
Novadoz Pharmaceuticals LLC
Abiraterone acetate
Listed by CivicaScript, LLC
| Dosage form | Tablet |
|---|---|
| Route | Oral, Oral |
| Drug class | Cytochrome P450 17A1 Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 82249-011 |
| FDA application | ANDA208339 |
| RxNorm concept | 1100075 |
| Package sizes listed | 1 |
| Marketed since | November 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Abiraterone acetate
Novadoz Pharmaceuticals LLC
Abiraterone acetate
CivicaScript, LLC
Abiraterone acetate
Hikma Pharmaceuticals USA Inc.
Abiraterone acetate
Quallent Pharmaceuticals Health LLC
Abiraterone Acetate
BluePoint Laboratories
Abiraterone acetate
Quallent Pharmaceuticals Health LLC
Abiraterone acetate
Novadoz Pharmaceuticals LLC
Abiraterone acetate
Novadoz Pharmaceuticals LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.